| Literature DB >> 23150763 |
Xiang Zhou1, Jun-Ming Liao, Wen-Juan Liao, Hua Lu.
Abstract
The oncoprotein MDM2 is both the transcriptional target and the predominant antagonist of the tumor suppressor p53. MDM2 inhibits the functions of p53 via a negative feedback loop that can be circumvented by several ribosomal proteins in response to nucleolar or ribosomal stress. Stress conditions in the nucleolus can be triggered by a variety of extracellular and intracellular insults that impair ribosomal biogenesis and function, such as chemicals, nutrient deprivation, DNA damaging agents, or genetic alterations. The past decade has witnessed a tremendous progress in understanding this previously underinvestigated ribosomal stress-MDM2-p53 pathway. Here, we review the recent progress in understanding this unique signaling pathway, discuss its biological and pathological significance, and share with readers our insight into the research in this field.Entities:
Keywords: MDM2; MDMX; MDS; cancer; nucleolar stress; p53; ribosomal proteins; ribosomopathy
Year: 2012 PMID: 23150763 PMCID: PMC3494370 DOI: 10.1177/1947601912455200
Source DB: PubMed Journal: Genes Cancer ISSN: 1947-6019